Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
ABSTRACT Background: Azathioprine is a common first-line therapy for neuromyelitis optica spectrum disorder (NMOSD). Objective: The aim of this study was to determine whether long-term treatment (>10 years) with azathioprine is safe in NMOSD. Methods: We conducted a retrospective medical reco...
Saved in:
| Main Authors: | Ana Beatriz Ayroza Galvão Ribeiro GOMES, Milena Sales PITOMBEIRA, Douglas Kazutoshi SATO, Dagoberto CALLEGARO, Samira Luisa APÓSTOLOS-PEREIRA |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2021-03-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-10-01) -
Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01) -
Neuromyelitis Optica: A Case Report
by: Wei-Chia Chia, et al.
Published: (2010-12-01) -
Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01) -
Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01)